Work Text:
The withdrawal from the Japan Cup had been submitted in two lines.
That was the thing that had stayed with Matikanetannhauser afterwards — not the decision itself, which had arrived with the particular inevitability of something that had been coming for longer than she had admitted, but the administrative simplicity of it. Two lines. A form. And a signature. And then the race she had been building toward for the better part of a season was simply no longer hers to run.
She had held the confirmation slip for a long time before deciding to make the appointment.
The Department of Otolaryngology occupied a floor that was, by the hospital's general standards, orderly in the specific way of a department that dealt with small and complicated anatomical territories: The narrow corridors of the ear, the interconnected chambers of the sinuses, the particular precision required when the margin between function and failure was measured in millimetres. The waiting area was clean and unremarkable, with a diagram of the nasal passages on one wall that Tannhauser had been studying since she sat down with the particular attention of someone who had decided, this time, to come prepared.
She had looked things up. Epistaxis was the medical term for nosebleed, which she had found both useful to know and slightly less alarming than she had expected. The nasal vasculature. The sites where bleeds typically originated. She had read about Kiesselbach's plexus with the methodical diligence of someone who believed that understanding a problem was the first step toward not being at its mercy.
The bleeds had been happening since forever. But they had been worsening the past three years.
She had managed them with the tools available, like gauze, pressure, the tilt of her head, and the particular patience of sitting still while her body did something inconvenient. Her trainer had taken the time to arrange her training and racing schedule around the unpredictability of the nosebleeds with the logistical creativity of someone who had made an accommodation she should not have had to make.
The Japan Cup had been the point at which accommodation and reality had finally failed to align.
She had stood at the start of the warm-up and felt the familiar pressure behind her nose, and had known, with the specific knowledge of three years of experience, that today was going to be a bad day, and had stood for another thirty seconds trying to convince herself otherwise, and had then walked to the officials' table and done the thing she had been dreading.
Two lines. A form. A signature.
She looked at the diagram of the nasal passages on the waiting room wall.
Well, here we go, she thought to herself.
"Matikanetannhauser?"
The consultation room was arranged with the economy of a specialist who had learned that their work required precision tools, well-maintained and well-positioned, rather than an abundance of equipment. The examination chair was adjustable and positioned beneath a light source that was clearly intended for exactly the kind of close-range work that a nasal examination involved. A nasal endoscopy unit sat on a stand at the ready. The desk bore a file, a notepad, and a reference model of the nasal anatomy that looked consulted rather than displayed.
The doctor was already in the room.
She was compact and bright-eyed and gave the immediate impression of someone who moved through the world with the energy of a person genuinely engaged in it — not performing engagement, but inhabited by it. Her coat was neat, her hair managed with the practical efficiency of someone whose work required her full attention elsewhere. She had the quality, Tannhauser thought, of someone who could be several places at once and was choosing, right now, to be fully here.
"Hello! I'm Dr. Chambers. You may call me Rebecca, please." She offered her hand with a warmth that was specific rather than generic. "Come in, sit down. I've been looking forward to your case."
Tannhauser sat in the patient's chair and absorbed this. "You look forward to cases?"
"The interesting ones," Rebecca said, settling behind the desk with the ease of someone entirely at home in this room. "Yours qualifies." She opened the intake file. "Recurrent epistaxis, since childhood but worsened within the past three years, significant enough that it caused a withdrawal from…the Japan Cup?!" She glanced at Tannhauser. "Looks like we are indeed well past the threshold of 'occasional nosebleed' and into something that needs a proper investigation." She looked up. "I want to understand the full picture before we look at anything. Tell me about it from the beginning."
Tannhauser told her.
She had expected to feel self-conscious about it — about the three years of managing the worsening inconvenience alone, about the adaptive workarounds she'd built, about the withdrawal that had brought her here. Rebecca listened with the focused and forward-leaning attention of someone who was building a complete picture and knew that the picture built from the patient's own account was the most important one.
She asked questions at the right moments. Left side, right side, both? Predominantly the right, occasionally both; Duration of a typical episode? Variable, between five and thirty minutes, the longer ones following high-intensity effort; Frequency? Weekly at minimum, more during heavy training blocks; Any identifiable triggers beyond exercise? Dry air, certain seasons, anything else? Tannhauser thought about it honestly, without editing for brevity. Yes, the drier months were worse. Yes, high-altitude training had been particularly difficult.
"Any family history of bleeding disorders?" Rebecca asked.
"Not that I know of. But I don't know a great deal about my family history."
Rebecca made a note without comment. "Any bruising easily, or prolonged bleeding from other small cuts or injuries?"
Tannhauser considered. "My bruises take longer than most people's to fade. I'd assumed that was training."
"It may be. It may also be relevant." Rebecca closed the notepad briefly. "I want to ask about the Japan Cup before we go further, because I think it matters for understanding why you're here now rather than earlier."
Tannhauser looked at her.
"You've been managing this for three years and longer," Rebecca said, with the directness of someone who was making an observation rather than a judgment. "You had built a schedule around it, you found techniques, you continued to race. That takes considerable competence and considerable effort." She paused. "And then the Japan Cup crossed a line that the previous management didn't reach. What was different about that day?"
Tannhauser was quiet for a moment.
"It wasn't different," she said. "That's the thing. It was exactly the same as all the other bad days. But this one had the Japan Cup attached to it." She looked at the anatomical model on the desk. "I realised…I'd been building my entire racing preparation around the assumption that I could keep managing it. And then I had the day where I couldn't, and the thing I'd been managing around was — " she paused "— not a race I could get back."
"Yes," Rebecca said, with the simplicity of someone who understood what had just been said and did not intend to say less than it deserved. "That's a very clear articulation of why this matters."
Rebecca began with the basic assessment — blood pressure, which was relevant; a brief neurological screening, which was relevant given the duration and frequency; a careful review of the head and neck structures externally. She worked with the economy of someone who had been trained to extract maximum information from systematic process without making the extraction feel mechanical.
Then she brought the examination chair upright and explained the nasal endoscopy to a bewildered Tannhauser
"This is a thin, flexible camera called nasal endoscope. It lets me see the interior of the nasal cavity directly," she said, as she prepared the equipment. "I'll apply a topical anaesthetic first, so it won't hurt. It will feel like pressure and you'll be aware of it, but it shouldn't be painful. I need to see the mucosal tissue, the vasculature at the anterior septum, and the posterior regions that surface examination can't reach." She looked at Tannhauser. "This is where most of the important information will be."
"Kiesselbach's plexus," Tannhauser said.
Rebecca, slightly stunned, looked at her.
"I read about it before the appointment," Tannhauser said.
"You did your research!" Rebecca exclaimed, and the look she gave her was the specific one that appeared when she found something genuinely pleasing. "Yes. That's the most common site for anterior bleeds. The anterior ethmoid and sphenopalatine vessels are the posterior concern." She picked up the anaesthetic applicator. "Let's see what we're looking at."
She worked in the particular quiet of someone performing a close examination that was focused and methodical. Her attention was entirely at the tip of the endoscope. Tannhauser sat still with the practised stillness of an athlete who had learned that stillness, like most skills, was trainable, and looked at the opposite wall and breathed evenly.
"Hmm," Rebecca said, after a while.
Then, a moment later: "There it is."
Then: "And there."
"Can you tell me what you're seeing?" Tannhauser asked.
"Yes — I'll walk you through it in a moment. I'm going to look at the posterior regions as well before I summarise."
She looked. She made small adjustments. She was quiet in the way of someone who was reading something they needed to read all of before they could say what it meant.
Then she withdrew the endoscope and turned to the monitor where the captured images were already displaying.
"Come look," she said.
Tannhauser turned the chair toward the monitor.
Rebecca walked her through it with the precision of someone who believed that a patient who understood their own anatomy was a patient who could participate meaningfully in their own care.
"This region here — " she indicated the anterior septum on the image "— is Kiesselbach's plexus, as you already know. The vascular density here is normal. What's not normal…is this." She zoomed in. "The mucosal tissue overlying the vessels is thinned. Significantly, in several areas. This means the vessels have reduced protective covering — they're closer to the surface, and therefore more vulnerable to rupture under conditions of increased blood pressure, dryness, or mechanical stress."
"Exercise," Tannhauser said.
"Well, that, and altitude, dry environments, basically anything that increases nasal blood flow or reduces mucosal moisture. All the triggers you identified." Rebecca pointed to a second area. "And here, posteriorly, there's a vessel with some irregular architecture. Slightly enlarged, branching pattern not entirely typical. This is the one that concerns me most for the longer, heavier bleeds."
"Is it structural? Was I born with it, or did it develop one way or another?"
"Both, potentially," Rebecca said, and it was clear this was a distinction she had been considering. "The mucosal thinning can be partly constitutional, since some people's nasal mucosa is simply thinner, and can also be exacerbated by years of frequent bleeds, because the tissue undergoes cycles of trauma and repair. The posterior vessel seems more likely constitutional." She looked back at Tannhauser. "Which brings me to the question I want to pursue today from a different angle."
Rebecca opened a second screen.
"My background," she said, "is in biochemistry before ENT. I spent a significant part of my research career working at the intersection of haematological function and mucosal biology." She said this not with pride but with the practical directness of someone explaining a tool she was going to use. "Advances in biochemical analysis over the last decade have substantially changed what we can determine about the vascular and mucosal environment from tissue and blood profiling, not just from what we can see with a camera."
"Meaning there's more than just this endoscopy."
"Correct. The endoscopy tells me the structural picture. Biochemistry tells me the why of the structure." She pulled up a reference panel for the curious Uma to observe. "The thinning you have, at the level you have it, at your age and with your athletic profile, doesn't fully match simple constitutional variation. I want to look at your coagulation factors — specifically the von Willebrand panel, and factor levels VIII and IX. I also want a biochemical workup on your mucosal inflammatory markers and your platelet function assay."
Tannhauser looked at the list.
"You think it's a clotting issue," she said.
"I do think there might be a clotting component," Rebecca said, carefully precise. "Von Willebrand disease, particularly Type 1, is one of the most underdiagnosed bleeding conditions in women, including Uma Musume, and it presents exactly like this: Recurrent nosebleeds, prolonged bruising, symptoms that are manageable enough that they get managed rather than investigated." She met Tannhauser's eyes. "A long time weekly nosebleeds worsening within three years in a young athlete that have required you to restructure your entire training programme is not normal epistaxis. That's a sentence that someone should have said to you a long time ago."
Tannhauser looked at the endoscopy images on the screen. At the thinned tissue, the irregular vessel, and the picture of three years assembled in anatomical detail.
"No one else ordered this panel if I remember correctly" she said.
Rebecca didn't say anything else, because her patient's observation was its own complete thing.
The blood draw was brief and systematic. Rebecca labelled each tube in the order of processing priority and explained the turnaround: the coagulation factors within forty-eight hours, the mucosal markers slightly longer, and the platelet function assay at the same time. She would contact Tannhauser directly when the full picture was available.
"While we wait," Rebecca said, returning to the desk and writing, "I want to address the immediate management. Not as a permanent solution, since that depends on the results, but to reduce the frequency and severity of bleeds in the interim."
The interim plan was specific: a saline nasal rinse protocol, twice daily, to support mucosal hydration; a vitamin K topical preparation for the anterior mucosal sites; a modified training protocol for high-intensity sessions, with practical parameters she wrote out clearly. And one additional item.
"Anterior nasal packing training," Rebecca said.
Tannhauser looked at her with a confused gaze.
"You've been managing these bleeds with gauze and pressure," Rebecca continued. "That is correct, and you've indeed been doing it right. But for the longer posterior bleeds — the ones that go beyond fifteen minutes — there are more effective first-line interventions, and I want you to know how to use them." She produced a small kit from the supply cabinet. "I'm going to show you now, while you're in the chair, so that the next time you're standing at a race start and it happens, you have more than one option."
Tannhauser looked at the kit.
"You're teaching me to manage it better," she said. "Until we know what it is."
"I'm teaching you to be less at its mercy," Rebecca said, with the specific precision of someone who had chosen those words deliberately. "There's a difference."
The training took twenty minutes. Rebecca was patient and clear — explaining each step before demonstrating it, asking Tannhauser to repeat the key elements back, confirming understanding with the thoroughness of someone who took the transfer of clinical skill seriously.
When they were done, Tannhauser sat with the small kit in her hands and the printed interim protocol on the desk beside her and the blood draw request on top of that.
"If it is von Willebrand," she said. "What does treatment look like?"
"Depends on the type and severity," Rebecca said. "Type 1, which is what I'm most suspecting, responds well to desmopressin, or DDAVP, which stimulates the release of the patient's own von Willebrand factor. For higher-demand situations like a major race, it can be given as a nasal spray beforehand. It's used routinely in athletes with this condition." She paused. "If it's Type 2 or 3, the approach is different, but those are less common. The point is: if it's vWD, there is a management pathway. It doesn't mean the racing stops."
Tannhauser held this.
The Japan Cup had been a withdrawal in two lines. The thought of a future race that was simply a race — with a protocol, with a medication, with the thing no longer being something to manage around but something that had been addressed — was, she found, a surprisingly substantial thing to hold.
"The biochemistry," she said. "Your research background. Is that what made you look for this when others didn't?"
Rebecca considered the question with the honesty it deserved. "You could say that," she said. "I came to ENT through the molecular side of mucosal biology. I look at the tissue, and I also look at what the tissue is made of and how it behaves at the cellular level. When the two pictures don't match, when the structural presentation is worse than the patient history alone would predict…I want to know why."
"The tissue was telling you something the history didn't say."
"Yes," Rebecca said. "And the history was telling me something the tissue alone wouldn't show. You need both." She paused. "You kept a very clear track of your symptoms over basically the course of your entire life, but especially these past three years. That data is part of why I could see the full picture. Your records of the frequency, the duration, the triggers…that's the kind of history that makes a diagnosis possible."
Tannhauser thought about the logistical workarounds she and her trainer had built, namely the tracking, scheduling, and accommodation. She had thought of it as managing a problem. She understood now that she had also been building, without knowing it, the evidence that would eventually name the problem correctly.
"Three years," she said.
"Yes," Rebecca said, without softening it. "That's the honest answer. And you deserve an honest answer about the timeline." She met her eyes. "But you're here now. The picture is clearer than it was this morning. And the next steps are terrifically specific."
Tannhauser left the department with the blood draw request, the interim care plan, the small kit, the printed instructions for its use, and the appointment card for the results review in forty-eight hours.
She stood at the lift and held all of this and thought about three years.
She thought about the Japan Cup withdrawal — the two lines, the form, the signature. The specific helplessness of a problem that kept arriving and kept being managed and never being explained, never being named, never being given the full attention it had warranted from the beginning.
She thought about Rebecca saying: I'm teaching you to be less at its mercy.
She thought about what it would be like to stand at a start line and not be measuring the probability of disaster. To have run the Japan Cup. To have raced the season she had planned, without the architecture of accommodation underneath it.
That was, she thought, not the past. The past had been what it had been. But it was possibly the future, and the future was the direction she was going.
The lift doors opened.
She stepped in with the small kit in her bag and the printed interim protocol in her hand and the knowledge — not a cure, not yet, but the shape of an answer — that she had arrived at this department three years late and had been seen clearly once she got here.
Forty-eight hours for the results.
She can wait forty-eight hours.
She had been managing this for three years. Forty-eight hours was manageable.
The lift descended, and she let it, and thought about racing — not the race she had lost, but the races that were, somewhere ahead in the calendar, still waiting to be run.